Highlights
- 1Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
Publications
140 publications
Funding
25 grantsView NIH portfolio on RePORTER ↗
Active
4 grants- Co-IThe effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normalNational Institute on Aging · 2020–2027R01AG068398-05
- PIMechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target EngagementNational Institute of Neurological Disorders and Stroke · 2020–2027R01NS116887-05
- Sub-PITreatment Strategies for Mitochondrial DiseaseU.S. Department of Defense · 2022–2026 · via Columbia UniversityW81XWH-20-1-0807
- KPNew PET/CT System for Human and Non-human Primate ImagingOffice of the Director, NIH · 2023–2026S10OD034271-01
Completed grants (21)
- PIService agreement with Neuronasal, Inc. (2025)Neuronasal · 2025–2025ContractSA 253159-01
- Sub-PIThe Gulf War Illness Clinical Trials and Interventions Consortium (GWICTIC)U.S. Department of Defense · 2020–2025 · via Nova Southeastern UniversityW81XWH-18-2-0062
- KP7T Magnetic Resonance Imaging System for Basic, Translational and Clinical ResearchOffice of the Director, NIH · 2021–2025
- PIBiomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaNational Institute of Mental Health · 2017–2023R01MH110270-05
- MPICornell ME/CFS Collaborative Research CenterNational Institute of Neurological Disorders and Stroke · 2017–2023 · via Cornell University - IthacaU54NS105541-05
- PIBiomarkers and Brain Mechanisms of Gulf War IllnessU.S. Department of Defense · 2015–2022W81XWH-15-1-0437
- KPOptimized Multi-Metabolite Edited MRS at 3TNational Institute of Biomedical Imaging and Bioengineering · 2021–2022K99EB028828-02
- PIService agreement with Neuronasal, Inc.Neuronasal · 2021–2022ContractNeuro-214813
- Sub-PITreatment Strategies for Mitochondrial DiseaseU.S. Department of Defense · 2020–2021 · via Columbia University Medical Center_W81XWH-19-PRMRP-FPA
- Sub-PIMitochondrial Encephalomyopathies: Approaches to TreatmentEunice Kennedy Shriver National Institute of Child Health and Human Development · 2014–2020 · via Columbia UniversityP01HD080642-05
- Sub-PINeuroinflammation and PVS Deficits in AdolescentsNational Institute of Mental Health · 2014–2018 · via Mount Sinai School of Medicine5 R01 MH10479-04
- PISpecificity and Validity of Oxidative Stress Model of Chronic Fatigue SyndromeNational Institute of Mental Health · 2013–2017R01MH100005-03
- Sub-PIThe Neuroimmunology of AnhedoniaNational Institute of Mental Health · 2012–2017 · via New York University School of Medicine (Grossman)R01MH095807-05
- PINovel OCD Medication Strategies to Target Brain Mechanisms in AdolescentsNational Institute of Mental Health · 2012–2017
- PIN-Acetylcysteine for Neuroprotection in Parkinsons DiseaseNational Institute on Aging · 2011–2016
- PIThe Antidepressant Action of Ketamine: Brain ChemistryNational Institute of Mental Health · 2011–2016
- Sub-PIMitochondrial Encephalomyopathies and Mental RetardationEunice Kennedy Shriver National Institute of Child Health and Human Development · 2011–2016 · via Columbia University· 2 renewalsP01HD032062-20 EW
- Sub-PINeuropathologic Abnormalities Define A Subgroup of Patients with CFSNational Institute of Neurological Disorders and Stroke · 2011–2015 · via Beth Israel Medical Center
- PINAC for Treatment of Oxidative Stress in Chronic Fatigue SyndromeNational Institute of Nursing Research · 2012–2015
- PINovel MRS Neurotechnology for Imaging GABA & Glutamate Function in SchizophreniaNational Institute of Mental Health · 2007–2012
Clinical research
3 studies
Active
2 studies- PINCT05241262A Multiple Ascending Phase 1 Dose Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsPHASE1 · Columbia University · OPEN TO ACCRUAL (as of 2023)Mitochondrial Disease
- PINCT04987775Mechanisms of Oxidative Stress During N-Acetyl Cysteine (NAC) Supplementation in Veterans With Gulf War Illness (GWI)EARLY_PHASE1 · Nova Southeastern University · OPEN TO ACCRUAL (as of 2022)Gulf War Syndrome
Completed & closed trials (1)
- PINCT04542161Mechanistic Assessment of N-Acetylcysteine as an Antioxidant Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Through Dose Response and Treatment Target EngagementPHASE2 · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2026)Chronic Fatigue Syndrome; Myalgic Encephalomyelitis